NPI registry status
Active
2026 NPPES data Otolaryngology Physician NPI 1205030806 MD
Verify on CMS → Michael Briscoe, MD
Otolaryngology Physician in Conroe, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,060 in Otolaryngology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
593
Medicare Part D claims · 298 beneficiaries · Otolaryngology Physician avg: 536
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.9/100
▲ 2 pts above national avg 83.5 · Above neutral
Industry payments
$1.0K
30 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Michael Briscoe, MD reported a CMS MIPS final score of 85.9/100 - above the 83.5 national average - and filed 593 Medicare Part D claims in 2024.
- 85.9/100
- MIPS score · +2 vs avg
- 593
- Part D claims, 2024
- 95%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Michael Briscoe, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1205030806), first enumerated 06/14/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 593 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 85.9/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$1.0K in reported industry payments (30 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Michael Briscoe, MD's individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1205030806 · Otolaryngology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-INLINE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1205030806
- ENUM-MID 2007
- TAX-MID 11K Otolaryngology Physician
- MIPS-INLINE 85.9/100
- RX-LIGHT 593
- BOOK-LIGHT 787 in Texas
- PHOTO-FINISH Patrick Chiles · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Briscoe · this p…
Briscoe · this provider
85.9 MIPS pts
- Erinn White · hi…
Erinn White
85.9 MIPS pts
- Patrick Chiles ·…
Patrick Chiles
85.9 MIPS pts
- Eric Fung · near
Eric Fung
85.9 MIPS pts
- Amy Reynders · n…
Amy Reynders
85.9 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Michael Briscoe, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
86 ≥ 46th percentile 46% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Briscoe, MD sits
This provider among otolaryngology physician peers
Across the 3,290 otolaryngology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Briscoe, MD writes more Part D claims than 63% of them and scores higher on MIPS quality than 53% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one otolaryngology physician peer from a representative sample of 60; the gold marker is Michael Briscoe, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Michael Briscoe, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Briscoe, MD?
High performer (top quartile)Primary specialty
Otolaryngology Physician
Medicare Part D claims
593 11% vs specialty avg
MIPS final score
85.9/100 2.4 pts vs avg
Specialty distribution in Texas
How Otolaryngology Physician compares to other specialties among Texas providers
Medicare quality performance, MIPS
Michael Briscoe, MD's 2023 MIPS final score plotted against the Otolaryngology Physician national average
- MIPS Final Score
- 85.9/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1205030806 |
|---|---|
| Specialty | Otolaryngology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/14/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
85.8862
Final Score
Measured-score avg: 83.5
75.4294
Quality
98
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Michael Briscoe, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Texas Ear, Nose And Throat Specialists, PLLC
The Woodlands, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Briscoe, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.0K
Largest payer
Hologic Sales and Service, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Michael Briscoe, MD. To verify Michael Briscoe, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Michael Briscoe, MD - brand share 5.0%
Otolaryngology Physician average
5% brand-name claims vs 95% generic, on 593 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
593
Total Claims
$20K
Total Drug Cost
298
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 824.467
- Total Day Supply
- 20,255
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $7K
- Generic Drug Cost
- $13K
- Antibiotic Claims
- 52
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 1.34
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 13, 65-74: 155, 75-84: 99, 85+: 31
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Michael Briscoe, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ipratropium Bromide
Ipratropium Bromide
159 claims
- Fluticasone Propio…
Fluticasone Propionate
92 claims
- Fluocinolone Aceto… 46
Fluocinolone Acetonide Oil
46 claims
- Mupirocin 30
Mupirocin
30 claims
- Ofloxacin 29
Ofloxacin
29 claims
- Levocetirizine Dih… 22
Levocetirizine Dihydrochloride
22 claims
- Diclofenac Sodium 18
Diclofenac Sodium
18 claims
- Epinephrine 15
Epinephrine
15 claims
| Drug | Claims |
|---|---|
| Ipratropium Bromide | 159 |
| Fluticasone Propionate | 92 |
| Fluocinolone Acetonide Oil | 46 |
| Mupirocin | 30 |
| Ofloxacin | 29 |
| Levocetirizine Dihydrochloride | 22 |
| Diclofenac Sodium | 18 |
| Epinephrine | 15 |
| Levofloxacin | 15 |
| Clindamycin Hcl | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otolaryngology Physician Overview
How Michael Briscoe, MD fits within the Otolaryngology Physician landscape nationally.
11,060
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
536
Avg Claims per Provider
Michael Briscoe, MD's 593 claims are above the specialty average of 536.
Nationwide Otolaryngology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Briscoe, both outside Texas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (85.9 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Otolaryngology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Briscoe.
One of 787 Otolaryngology Physician providers enrolled in Texas, 5 are shown here.
Dr. Jason Acevedo
MD
Abilene, TX
Jason Adams
Jbsa Ft Sam Houston, TX
Dr. Jane Admire
MD
Dallas, TX
Dr. Robert Africa
MD
Galveston, TX
Dr. Ashley Agan
MD
Dallas, TX
Compare Otolaryngology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Michael Briscoe, MD's specialty? ▼
Michael Briscoe, MD specializes in Otolaryngology Physician and practices in Conroe, Texas. Credentials: MD.
How much does Michael Briscoe, MD prescribe under Medicare Part D? ▼
In 2024, Michael Briscoe, MD wrote 593 Medicare Part D claims totaling $20K in drug costs for 298 beneficiaries.
What is Michael Briscoe, MD's Medicare quality score? ▼
Michael Briscoe, MD has a CMS MIPS Final Score of 85.9/100 (Quality: 75.4). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Michael Briscoe, MD located? ▼
Michael Briscoe, MD is located at 1501 RIVER POINTE DR STE 120, Conroe, TX, 77304. Phone: (936) 539-4700.
What is Michael Briscoe, MD's NPI number? ▼
Michael Briscoe, MD's National Provider Identifier (NPI) is 1205030806, issued on 06/14/2007.
Does Michael Briscoe, MD prescribe more brand-name or generic drugs? ▼
Michael Briscoe, MD's prescribing is 5% brand-name and 95% generic drugs by claim count, with $7K in brand drug costs.
How many Otolaryngology Physician providers are there in the US? ▼
There are 11,060 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 536 Medicare Part D claims per year.
What drugs does Michael Briscoe, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Michael Briscoe, MD's most frequently prescribed drugs include Ipratropium Bromide, Fluticasone Propionate, Fluocinolone Acetonide Oil. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Briscoe, MD accept Medicare? ▼
Michael Briscoe, MD appears in CMS Medicare data with 593 Part D claims and 298 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Briscoe, MD's credentials? ▼
Michael Briscoe, MD's NPI is 1205030806 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.